Insider trading

Period: 120 months Stock: NEO + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

146 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

146 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

146 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

146 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
146 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
146 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

146 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
29 Sep 2020
JONES STEVEN C Director · indirect
Sold, plan not stated
$5.21M 141,049 at 36.95
10.5%
29 Sep 2020
JONES STEVEN C Director
Sold, plan not stated
$2.96M 81,000 at 36.55
45.3%
28 Sep 2020
JONES STEVEN C Director · indirect
Sold, plan not stated
$1.42M 38,951 at 36.34
2.8%
28 Sep 2020
JONES STEVEN C Director
Sold, plan not stated
$694.64K 19,000 at 36.56
9.6%
24 Sep 2020
CROWTHER BRUCE K Director
Sold, plan not stated
$291.74K 8,333 at 35.01
15.2%
22 Sep 2020
CROWTHER BRUCE K Director
Sold, plan not stated
$85.63K 2,400 at 35.68
4.9%
10 Sep 2020
JONES STEVEN C Director · indirect
Sold, plan not stated
$1.41M 37,991 at 37.13
2.7%
9 Sep 2020
JONES STEVEN C Director · indirect
Sold, plan not stated
$2.65M 71,583 at 36.98
4.8%
8 Sep 2020
JONES STEVEN C Director · indirect
Sold, plan not stated
$376.69K 10,426 at 36.13
0.7%
6 Aug 2020
CARDOZA GEORGE President, Pharma Services
Sold, plan not stated
$3.25M 82,500 at 39.35
19.0%
3 Aug 2020
Bonello William President, Informatics
Sold, plan not stated
$849.42K 22,000 at 38.61
64.6%
Sold half or more
3 Aug 2020
BALLIET JENNIFER VP and Chief Culture Officer
Sold, plan not stated
$510.25K 13,000 at 39.25
34.2%
30 Jul 2020
SHOVLIN ROBERT J. President, Clinical Services
Sold, plan not stated
$3.11M 81,356 at 38.17
35.4%
4 Mar 2020
SHOVLIN ROBERT J. President, Clinical Services
Sold, plan not stated
$3.03M 98,093 at 30.86
39.3%
2 Mar 2020
JONES STEVEN C Director · indirect
Sold, plan not stated
$7.21M 250,000 at 28.85
15.4%
2 Mar 2020
JONES STEVEN C Director · indirect
Sold, plan not stated
$712.00K 25,000 at 28.48
16.7%
2 Mar 2020
JONES STEVEN C Director · indirect
Sold, plan not stated
$564.80K 20,000 at 28.24
39.6%
2 Mar 2020
JONES STEVEN C Director · indirect
Sold, plan not stated
$64.95K 2,300 at 28.24
5.3%
10 Dec 2019
McKenzie Kathryn B Chief Accounting Officer
Sold, plan not stated
$210.96K 8,000 at 26.37
77.9%
Sold half or more
21 Nov 2019
JONES STEVEN C Director · indirect
Sold, plan not stated
$562.14K 23,162 at 24.27
1.5%
20 Nov 2019
JONES STEVEN C Director · indirect
Sold, plan not stated
$3.12M 128,068 at 24.35
7.6%
19 Nov 2019
VAN OORT DOUGLAS M Chairman and CEO · indirect
Sold, plan not stated
$4.52M 187,500 at 24.08
100%
Sold half or more
15 Nov 2019
BALLIET JENNIFER VP and Chief Culture Officer
Sold, plan not stated
$160.23K 6,833 at 23.45
23.0%
12 Nov 2019
CARDOZA GEORGE President, Pharma Services
Sold, plan not stated
$450.13K 19,444 at 23.15
5.6%
7 Nov 2019
CARDOZA GEORGE President, Pharma Services
Sold, plan not stated
$91.20K 4,000 at 22.80
1.3%
6 Nov 2019
CARDOZA GEORGE President, Pharma Services
Sold, plan not stated
$1.18M 51,556 at 22.82
14.5%
1 Nov 2019
SHOVLIN ROBERT J. President, Clinical Services
Sold, plan not stated
$814.11K 35,801 at 22.74
19.7%
31 Oct 2019
SHOVLIN ROBERT J. President, Clinical Services
Sold, plan not stated
$1.63M 70,473 at 23.11
28.0%
10 Sep 2019
JONES STEVEN C Director · indirect
Sold, plan not stated
$25.76K 1,200 at 21.47
2.5%
9 Sep 2019
JONES STEVEN C Director · indirect
Sold, plan not stated
$75.00 3 at 25.00
0.0%
6 Sep 2019
JONES STEVEN C Director · indirect
Sold, plan not stated
$42.28K 1,691 at 25.00
0.1%
30 Aug 2019
JONES STEVEN C Director · indirect
Sold, plan not stated
$30.00K 1,200 at 25.00
0.1%
28 Aug 2019
JONES STEVEN C Director · indirect
Sold, plan not stated
$989.22K 39,537 at 25.02
2.3%
28 Aug 2019
Bonello William Chief Strategy Officer
Sold, plan not stated
$422.11K 17,000 at 24.83
71.6%
Sold half or more
27 Aug 2019
JONES STEVEN C Director · indirect
Sold, plan not stated
$755.49K 30,280 at 24.95
1.7%
26 Aug 2019
JONES STEVEN C Director · indirect
Sold, plan not stated
$3.57M 143,603 at 24.87
7.6%
26 Aug 2019
HIPP RAYMOND R Director
Sold, plan not stated
$382.36K 15,424 at 24.79
10.3%
26 Aug 2019
Johnson Kevin C Director
Sold, plan not stated
$291.93K 11,800 at 24.74
29.4%
23 Aug 2019
Johnson Kevin C Director
Sold, plan not stated
$1.05M 41,200 at 25.60
50.7%
Sold half or more
23 Aug 2019
JONES STEVEN C Director · indirect
Sold, plan not stated
$191.77K 7,456 at 25.72
0.4%
23 Aug 2019
HIPP RAYMOND R Director
Sold, plan not stated
$15.01K 600 at 25.02
0.4%
8 May 2019
HIPP RAYMOND R Director
Sold, plan not stated
$2.65M 118,479 at 22.36
46.3%
7 May 2019
HIPP RAYMOND R Director
Sold, plan not stated
$712.69K 31,521 at 22.61
11.0%
6 May 2019
Bonello William Chief Strategy Officer
Sold, plan not stated
$169.42K 7,200 at 23.53
51.7%
Sold half or more
3 May 2019
CARDOZA GEORGE President, Pharma Services
Sold, plan not stated
$3.46M 151,676 at 22.82
33.5%
3 May 2019
BALLIET JENNIFER VP and Chief Culture Officer
Sold, plan not stated 2×
$682.20K 30,000 at 22.74
56.8%
Sold half or more
2 May 2019
SHOVLIN ROBERT J. President, Clinical Services
Sold, plan not stated 2×
$2.64M 119,347 at 22.14
42.4%
4 Mar 2019
BALLIET JENNIFER VP and Chief Culture Officer
Sold, plan not stated
$267.26K 14,000 at 19.09
38.0%
28 Feb 2019
BALLIET JENNIFER VP and Chief Culture Officer
Sold, plan not stated
$587.10K 30,000 at 19.57
60.0%
Sold half or more
27 Feb 2019
JONES STEVEN C Executive Vice President · indirect
Sold, plan not stated
$4.78M 252,881 at 18.90
11.7%
Showing 51–100 of 146. ← Newer Page 2 of 3 Older →